Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion - The Wall Street Journal
10/23/23 at 10:55am
Organization
The Wall Street Journal
Author
Adrià Calatayud
25 words
0
Comments
Swiss pharmaceutical giant seeks to bolster pipeline
Business & Industrial
Drugs & Medications
Health Conditions
Roche
Bowel-Disease Drug From Roivant
Pfizer
Wall Street Journal Swiss
You are the first to view
https://www.wsj.com/health/pharma/roche-to-buy-telavant-from-roivant-sciences-and-pfizer-in-7-25-bln-deal-638ccc3c
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...